SEARCH

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    New Experimental Drug Enlicitide May Cut "Bad" Cholesterol By Up To 60%

    1 hour ago

    A new daily oral medication, enlicitide, has shown reductions in LDL cholesterol of up to 60% in a late-stage Phase 3 trial, matching the efficacy of injectable PCSK9 inhibitors.
    Click here to Read more
    Prev Article
    CSK's Post For Sanju Samson Fuels Trade Speculations Amid Talks With Rajasthan Royals
    Next Article
    Scientists Discover Rare Spider That Is Half-Female And Half-Male

    Related Breaking News Updates:

    Comments (0)

      Leave a Comment